Is Mogamulizumab an immunotherapy?
Is Mogamulizumab an immunotherapy? Mogamulizumab is an investigative immunotherapy being developed by Kyowa Hakko Kirin (KHK), of Japan, to treat patients with certain advanced cancers who have no other suitable treatment options. What is Mogamulizumab used for? Mogamulizumab-kpkc injection is used to treat mycosis fungoides and Sézary syndrome, two types of cutaneous T-cell lymphoma ([CTCL], […]